Antios Therapeutics

About:

Antios Therapeutics is a biopharmaceutical company developing innovative therapies for viral diseases.

Website: http://antiostherapeutics.com/

Top Investors: Fonds de solidarité FTQ, RA Capital Management, EPIQ Capital Group, Lumira Ventures, Adage Capital Management

Description:

Antios Therapeutics is a biopharmaceutical company devoted to developing innovative therapies for viral diseases. With an experienced and proven leadership team, the company is focused on the development of its oral drug candidate for potentially curative treatment of HBV infections. Antios Therapeutics was founded by Abel De La Rosa, Douglas Mayers, and Idean Marvasty.

Total Funding Amount:

$200M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Atlanta, Georgia, United States

Founded Date:

2018-01-01

Contact Email:

info(AT)antiostherapeutics.com

Founders:

Abel De La Rosa, Douglas Mayers, Idean Marvasty

Number of Employees:

11-50

Last Funding Date:

2021-11-03

IPO Status:

Private

Industries:

© 2025 bioDAO.ai